10-Q Filing

HealthLynked Corp CIK: 1680139 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-042938`
Period End Date	20210630
Filing Date	20210816
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	f10q0621_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 112 Cash Flow Statement 104 Stockholders Equity 44

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$356.08K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$2.59M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2021 and December 31, 2020, respectively	`AccountsReceivableNetCurrent`	$84.57K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of June 30, 2021 and December 31, 2020, respectively	`AccountsReceivableNetCurrent`	$87.15K	USD	Point-in-time
Inventory	`InventoryNet`	$112.72K	USD	Point-in-time
Inventory	`InventoryNet`	$95.20K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$59.00K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$51.45K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.84M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$403.54K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$177.46K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $231,878 and $177,457 as of June 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	$437.29K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $231,878 and $177,457 as of June 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	$390.26K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$231.88K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $515,482 and $151,776 as of June 30, 2021 and December 31, 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.24M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$151.78K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $515,482 and $151,776 as of June 30, 2021 and December 31, 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.60M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$515.48K	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$718.18K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$435.86K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Assets	`Assets`	$10.33M	USD	Point-in-time
Total Assets	`Assets`	$8.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.97M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	228.78M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	228.78M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$869.94K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.97M	shares	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$70.85K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$89.42K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$150.25K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$296.64K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	-	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	$411.43K	USD	Point-in-time
Common stock issuable, par value	`CommonStockParValue`	0.00	shares	Point-in-time
Common stock issuable, par value	`CommonStockParValue`	0.00	shares	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of June 30, 2021 and December 31, 2020, respectively	`ConvertibleDebtCurrent`	-	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of June 30, 2021 and December 31, 2020, respectively	`ConvertibleDebtCurrent`	$1.34M	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.15M	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.84M	shares	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$701.96K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$389.19K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.88M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.93M	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	$722.51K	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	$450.00K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$1.28M	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$798.48K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$273.79K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$377.18K	USD	Point-in-time
Total Liabilities	`Liabilities`	$6.68M	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.03M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 228,776,097 and 187,967,881 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$22.88K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 228,776,097 and 187,967,881 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$18.80K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,836,896 and 2,150,020 shares as of June 30, 2021 and December 31, 2020, respectively	`CommonStockIssuableValue`	$407.83K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,836,896 and 2,150,020 shares as of June 30, 2021 and December 31, 2020, respectively	`CommonStockIssuableValue`	$262.27K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$22.85M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$35.98M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.11M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.17M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.30M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$8.03M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.33M	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.45M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.98M	USD	2 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.11M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.47M	USD	1 Quarter
Consulting and event revenue	`ConsultingAndEventRevenue`	$50.42K	USD	1 Quarter
Consulting and event revenue	`ConsultingAndEventRevenue`	$50.42K	USD	2 Qtrs
Consulting and event revenue	`ConsultingAndEventRevenue`	$159.52K	USD	2 Qtrs
Consulting and event revenue	`ConsultingAndEventRevenue`	$71.86K	USD	1 Quarter
Product revenue	`ProductRevenue`	-	USD	1 Quarter
Product revenue	`ProductRevenue`	-	USD	2 Qtrs
Product revenue	`ProductRevenue`	$168.21K	USD	1 Quarter
Product revenue	`ProductRevenue`	$350.87K	USD	2 Qtrs
Total revenue	`Revenues`	$1.16M	USD	1 Quarter
Total revenue	`Revenues`	$1.71M	USD	1 Quarter
Total revenue	`Revenues`	$2.50M	USD	2 Qtrs
Total revenue	`Revenues`	$3.50M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.32M	USD	2 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$903.03K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$555.09K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.57M	USD	2 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.08M	USD	2 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.24M	USD	2 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$521.02K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$511.00K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$197.46K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$64.24K	USD	2 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$408.97K	USD	2 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$64.24K	USD	1 Quarter
Cost of product revenue	`CostOfRevenues`	-	USD	2 Qtrs
Cost of product revenue	`CostOfRevenues`	-	USD	1 Quarter
Cost of product revenue	`CostOfRevenues`	$328.59K	USD	2 Qtrs
Cost of product revenue	`CostOfRevenues`	$160.00K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$646.31K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.16M	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.51M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$206.47K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$49.66K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$418.13K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$24.87K	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$6.48M	USD	2 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$3.68M	USD	2 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$1.81M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$3.13M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-650.02K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.18M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.98M	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-896.37K	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-428.44K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	2 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$632.83K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-155.67K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-119.70K	USD	2 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-465.11K	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	2 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-172.95K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$-13.67K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	2 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$726.68K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-45.31K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-38.69K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$274.61K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-361.09K	USD	2 Qtrs
Interest income (expense)	`InterestIncomeexpense`	$8.96K	USD	2 Qtrs
Interest income (expense)	`InterestIncomeexpense`	$120.60K	USD	2 Qtrs
Interest income (expense)	`InterestIncomeexpense`	$58.42K	USD	1 Quarter
Interest income (expense)	`InterestIncomeexpense`	$-1.62K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-920.41K	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-5.35M	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-867.83K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$909.06K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.33M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.10M	USD	2 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-505.76K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.52M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.52M	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	-	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$176.79K	USD	2 Qtrs
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	-	USD	2 Qtrs
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.52M	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.51M	USD	2 Qtrs
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-594.16K	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.10M	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	2 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.54M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	228.01M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	118.88M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	220.82M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.88M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	220.82M	shares	2 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	228.01M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.54M	shares	1 Quarter

Cash Flow Statement 104 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.52M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$206.47K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$49.66K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$418.13K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$24.87K	USD	1 Quarter
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$207.78K	USD	2 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$461.22K	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	-	USD	2 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$465.11K	USD	2 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$726.68K	USD	2 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	-	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-896.37K	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-428.44K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$632.83K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$19.25K	USD	2 Qtrs
Change in fair value of debt	`NoncashExpense`	$119.70K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-45.31K	USD	2 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-361.09K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.58K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-15.36K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$17.52K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$34.74K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-74.67K	USD	2 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$23.12K	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$159.51K	USD	2 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$50.45K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-141.53K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-90.49K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$52.31K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$156.08K	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	-	USD	2 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$32.21K	USD	2 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$2.25K	USD	2 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-18.58K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.09M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.26M	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$164.00K	USD	2 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$196.00K	USD	2 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$47.00K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.40K	USD	2 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.04K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-203.40K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-214.05K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.65M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$724.69K	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$293.95K	USD	2 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	2 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$746.76K	USD	2 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	-	USD	2 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	$149.00K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$151.44K	USD	2 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Proceeds from government loans	`ProceedsFromGovernmentLoans`	$745.87K	USD	2 Qtrs
Proceeds from government loans	`ProceedsFromGovernmentLoans`	-	USD	2 Qtrs
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	$51.11K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.89M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.55M	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.43M	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$245.64K	USD	2 Qtrs
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$356.08K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.59M	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$356.08K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.59M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$29.34K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	2 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$187.00K	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$32.43K	USD	2 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.08M	USD	2 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	2 Qtrs
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	2 Qtrs
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	-	USD	2 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$43.30K	USD	2 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	-	USD	2 Qtrs
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$201.68K	USD	2 Qtrs
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$1.06M	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	-	USD	2 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$115.65K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$103.07K	USD	2 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	-	USD	2 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	2 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	2 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time
Acquisition of Cura Health Management LLC	`StockIssuedDuringPeriodValueAcquisitions`	$201.68K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$177.68K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.98M	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$253.78K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$348.60K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$1.41M	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$33.48K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$88.83K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$82.32K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$652.56K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$533.28K	USD	1 Quarter
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	1 Quarter
Fair value of modifications of warrant expiration dates to extend convertible notes payable	`FairValueOfModificationsOfWarrantExpirationDatesToExtendConvertibleNotesPayable`	-	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.43K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$86.81K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$237.33K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$43.70K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$66.88K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$63.66K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$38.58K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$37.41K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$39.41K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$215.00K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$676.72K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$13.30K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$3.15K	USD	1 Quarter
Net loss	`ProfitLoss`	$-505.76K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-580.22K	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.82M	USD	1 Quarter
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.